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Spinal cord injury (SCI) is a devastating condition that leads to permanent disability because injured axons do not regenerate
across the trauma zone to reconnect to their targets. A prerequisite for axonal regeneration will be the prevention of retrograde
degeneration that could lead to neuronal death. However, the specific molecular mechanisms of axotomy-induced degeneration
of spinal-projecting neurons have not been elucidated yet. In lampreys, SCI induces the apoptotic death of identifiable descending
neurons that are “bad regenerators/poor survivors” after SCI. Here, we investigated the apoptotic process activated in identifiable
descending neurons of lampreys after SCI. For this, we studied caspase activation by using fluorochrome-labeled inhibitors of
caspases, the degeneration of spinal-projecting neurons using Fluro-Jade C staining, and the involvement of the intrinsic apoptotic
pathway by means of cytochrome c and V𝛼 double immunofluorescence. Our results provide evidence that, after SCI, bad-
regenerating spinal cord-projecting neurons slowly degenerate and that the extrinsic pathway of apoptosis is involved in this process.
Experiments using the microtubule stabilizer Taxol showed that caspase-8 signaling is retrogradely transported by microtubules
from the site of axotomy to the neuronal soma. Preventing the activation of this process could be an important therapeutic approach
after SCI in mammals.
1. Introduction
In humans, as in the other mammals, spinal cord injury
(SCI) causes permanent disability. In mammals, one of the
main reasons for the failure of recovery is caused by the
inability of axotomized axons to regenerate across the injury
site to reconnect to their targets. An important goal of current
research aiming to develop a therapy for SCI is to promote
the regeneration of damaged axons [1]. An important pre-
requisite for axonal regeneration would be the prevention of
retrograde degeneration that could cause neuronal death or
atrophy impeding the activation of axonal regrowth. Several
types of central nervous system (CNS) neurons die after they
suffer axonal damage. For example, retinal ganglion cells [2–
4] and motoneurons [5, 6] die after axotomy. However, there
is still some controversy whether spinal cord (SC) projecting
neurons of the brain ofmammals die after SCI. Several studies
have shown the death of at least some brain neurons after
SCI (opossum [7]; rats [8–12]; humans [13]). However, in
two recent studies using rats, no evidence was found for the
death of corticospinal neurons after SCI [14] and suggested
that these neurons suffer atrophy after SCI but do not die
[15]. The death or degeneration (atrophy) of descending
neurons following SCI seems to involve an apoptotic process.
This is suggested by the appearance of TUNEL staining and
activated caspase-3 immunoreactivity in descending neurons
of the brain (pontine reticular neurons [10]; corticospinal
neurons [9, 11]). But, more work is needed to fully understand
the molecular mechanisms that control the degeneration of
descending neurons of the brain following a traumatic SCI.
Hindawi
BioMed Research International
Volume 2017, Article ID 5953674, 12 pages
https://doi.org/10.1155/2017/5953674
2 BioMed Research International
In contrast to mammals, lampreys recover normal
appearing locomotion spontaneously several weeks after a
complete SCI [16].This occurs due to the occurrence of plastic
changes [17–19] and regenerative processes [20–22] in spinal
circuits after the injury. Descending neurons of lampreys are
able to regenerate their axons after a complete SC transection
[23, 24] and a large percentage of spinal axons regener-
ate in their correct paths [16, 25]. Moreover, regenerated
descending axons are able to form new functional synapsis
with neurons below the site of injury [25–27]. Among the
reticulospinal neurons of the lamprey brain, there are 36
identifiable giant descending neurons [23], whose axons
project almost the entire length of the SC. These include the
Mauthner neurons, which have crossed descending axons,
and several pairs of Müller cells, which have ipsilateral
descending axons. Interestingly, these identifiable descending
neurons vary greatly in their regenerative abilities following
SCI [23]. Some of these neurons are considered “good regen-
erators” (i.e., they regenerate their axonmore than 55% of the
times) and others are considered “bad regenerators” (i.e., they
regenerate their axon less than 30% of the times). Thus,
lampreys offer a model where there is an opportunity to
study both enhancement and inhibition of regeneration in
the same preparation. An additional advantage of the sea
lamprey model of SCI is that the identifiable descending
neurons and their descending axons can be visualized in vivo
and in CNS whole-mounts due to the transparency of the
lamprey brain. This allows to study the intrinsic molecular
processes that determine the fate of axotomized neurons
following SCI. For example, recent studies have shown that
the differential expression of axonal guidance receptors in
good or bad regenerators can explain, at least in part, their
different regenerative abilities [22].
We and others have recently reported that a complete SCI
induces the delayed death of lamprey descending neurons
that, at earlier times after injury, had been identified as
bad regenerators [28, 29]. The occurrence of cell death was
determined based on the disappearance of Nissl staining,
the loss of neurofilament expression, the absence of labeling
when using retrograde tracers [28], and the early staining
of these neurons with Fluoro-Jade C (FJC) [29], which is a
marker for degenerating neurons. In addition, the appearance
of TUNEL staining [28] and activated caspases [30–32] in
the soma of axotomized descending neurons suggested that
their death after SCI is apoptotic. A recent report by Barreiro-
Iglesias and Shifman (2015) has shown that caspase activation
in the cell perikarya of bad-regenerating descending neurons
of lampreys is preceded by the initial activation of caspases
in the axotomized axons at the lesion site within the first
hours after the injury. This suggests that the degenerative
process is initiated at spinal levels. These data indicate
that the identifiable descending neurons known to be “bad
regenerators” (i.e., the M1, M2, M3, I1, I2, Mth, B1, B3,
and B4 descending neurons) suffer a process of slow and
delayed degeneration after SCI and, therefore, are also “poor
survivors.”Thus, lampreys are a convenient vertebrate model
for the in vivo study of molecular mechanisms underlying the
death or degeneration of descending neurons after SCI.
Apoptosis is a process that occurs normally during devel-
opment and aging and as a homeostatic mechanism to main-
tain cell populations in tissues but that can be also activated
after cell damage [33]. In apoptosis, caspases are responsible
for proteolytic cleavages that lead to cell disassembly (effector
caspases) or that are involved in regulatory events (initiator
caspases) [34]. Research indicates that there are two main
apoptotic pathways: the extrinsic or death receptor pathway
and the intrinsic or mitochondrial pathway. The intrinsic
pathway is activated by genomic and metabolic stress, the
presence of unfolded proteins, and other factors that lead
to permeabilization of the outer membrane of mitochondria
and the release of apoptotic proteins, mainly cytochrome c,
into the cytosol. Apoptosis initiation through the intrinsic
pathway usually leads to the formation of the apoptosome
complex and the activation of the initiator caspase-9 [34].The
extrinsic or death receptor pathway involves the activation of
death receptors. This process leads to activation of initiator
caspase-8 or caspase-10 [34]. Recently, we adapted the use
of fluorochrome-labeled inhibitors of caspases (FLICA) to
detect the activation of caspases in whole-mount prepa-
rations of the sea lamprey brain following SCI [30]. We
observed that activated caspase-8 labeling appears in the
soma of “poor survivor” descending neurons within 2 weeks
following a SCI [30, 31] and that the appearance of activated
caspase-8 in the cell body was preceded by its activation
in the injured axon rostral to the site of injury [31]. This
suggests that the extrinsic pathway of apoptosis is activated
in descending neurons after axotomy. In the present study,
we aimed to (1) further define the activation of the extrinsic
apoptotic pathway in identifiable reticulospinal neurons after
SCI, (2) study the possible activation of the intrinsic apoptotic
pathway, and (3) determine how the injury signals get to the
cell body. Our results provide additional evidence that, after
SCI, the bad-regenerating spinal-projecting neurons slowly
degenerate, that only the extrinsic and not the intrinsic path-
way of apoptosis is involved in this process, and that caspase-8
signaling is transported to the soma of descending neurons by
microtubules.
2. Material and Methods
2.1. Animals. Wild type larval sea lampreys (Petromyzon
marinusL.), 10–14 cm in length (4–7 years old), were obtained
from streams feeding Lake Michigan (USA) or from the
RiverUlla (Spain) andmaintained in aerated freshwater tanks
at 16∘C until the day of use. Experiments were approved
by the Institutional Animal Care and Use Committee at
Temple University and the by the Bioethics Committee at
the University of Santiago de Compostela and the Conselleŕıa
do Medio Rural e do Mar of the Xunta de Galicia (code
JLPV/IId, Spain) and were performed in accordance with
European Union and Spanish guidelines on animal care and
experimentation.
2.2. Complete SC Transection. Before experiments, animals
(𝑛 = 57) were deeply anesthetized by immersion in lamprey
Ringer solution containing 0.1% tricaine methanesulfonate
(ScienceLab, Houston, TX, USA). Complete SC transections
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were performed as previously described [35]. Briefly, the SC
was exposed from the dorsal midline at the level of the fifth
gill. Complete transection of the SCwas performedwith Cas-
troviejo scissors and the transectionwas confirmed under the
stereomicroscope. After surgery, animals were kept on ice for
1 hour allowing the wound to air dry. Each transected animal
was examined 24 hours after surgery to confirm that there
was no movement caudal to the lesion site. A transection
was considered complete if the animal could move only its
head and body rostral to the lesion. Animals were allowed
to recover in aerated fresh water tanks at room temperature
for different times (2 weeks, 4 weeks, 6 weeks, 10 weeks,
or 4 months).
2.3. FJC Staining in Whole-Mounted Brain Preparations.
Fluoro-Jade C is a polyanionic fluorescein derivative and
is commonly used in neuroscience to stain degenerating
neurons in the central nervous system, regardless of specific
insult or mechanism of cell death [36, 37]. In the present
study, FJC staining was used to further confirm that spinal-
projecting neurons of lampreys slowly degenerate after spinal
cord transection as shown previously with other markers of
cell death and degeneration [28].
Brains of control animals (𝑛 = 3) without a complete SC
transection (unlesioned) and brains of animals 4months (𝑛 =
5) after the SC transection were removed in ice-cold Ringer
and the dorsal choroid plexus covering the 4th ventricle was
removed.The posterior and cerebrotectal commissures of the
brain were cut along the dorsal midline, and the alar plates
were deflected laterally and pinned flat to a small strip of
Sylgard (Dow Corning Co., USA). Brains were fixed in 4%
paraformaldehyde (PFA) in phosphate buffered saline (PBS)
for 2 hours at room temperature and washed on a nutator
for 2 hours in PBS containing 2% Tween 20. Then, brains
were immersed in 80% ethanol solution containing 1%NaOH
for 5 minutes, then transferred to 70% ethanol solution for
2 minutes, and rinsed in water for 2 minutes. The brains
were incubated in 0.06% potassium permanganate solution
for 10min and rinsed in water for 2 minutes. The proper
dilution was made by making a 0.01% stock solution of FJC
dye (Chemicon, Temecula, CA, USA) in distilled water and
then adding 1mL of the stock solution to 99mL of 0.1% acetic
acid.The brains were immersed in the staining solution for 25
minutes and rinsed in water 3 times for 1 minute each. After
washes, brains were mounted on Superfrost Plus glass slides
(Fisher Scientific, MA, USA) and coverslipped using Prolong
(Invitrogen, USA) as an antifade reagent. Control brains were
processed in parallel with brains of animals 4 months after
injury.
2.4. Detection of Activated Caspases in Whole-Mounted
Brain Preparations. The Image-iT LIVEGreen Poly Caspases
Detection Kit (Cat. number I35104, Invitrogen, USA), Image-
iT LIVE Green Caspase-3 and -7 Detection Kit (Cat. number
I35106, Invitrogen), and the Image-iT LIVE Green Caspase-8
Detection Kit (Cat. number I35105, Invitrogen) were used to
detect activated caspases in identified reticulospinal neurons
of larval sea lampreys after a complete SC transection. These
kits contain 1 vial (component A of the kit) of the lyophilized
FLICA reagent (FAM-VAD-FMK for the detection of all
activated caspases, FAM-DEVD-FMK for the detection of
activated caspase-3 and caspase-7, and FAM-LETD-FMK for
the specific detection of activated caspase-8). Experiments
were done as previously described [30, 31]. Experiments for
the detection of all activated caspases were performed in
animals 2 weeks after the complete SC transection (𝑛 = 5).
Experiments for the detection of activated caspase-8 were in
animals 4 weeks (𝑛 = 4) after the complete SC transection.
Experiments for detection of activated caspase-3 and caspase-
7 were done in control unlesioned animals (𝑛 = 5) and in ani-
mals 6 weeks (𝑛 = 3) and 10 weeks (𝑛 = 4) after the complete
SC transection.
2.5. Double Cytochrome c and Complex V𝛼 Immunofluo-
rescence in Whole-Mounted Brain Preparations. Brains of
control unlesioned animals (𝑛 = 4), and animals 2 weeks
(𝑛 = 5) and 4 weeks (𝑛 = 5) after the complete SC transection
were dissected, fixed, and processed as for the FJC staining
(see above). After PFA fixation, brains were washed on a
nutator at room temperature twice (1 hour each wash) in PBS
containing 2% Tween 20 and then twice (30 minutes each
wash) inmaleate buffer containing 0.2%Tween 20.Thebrains
were immersed for 1 hour in maleate buffer containing 15%
normal goat serum (MitoSciences, Eugene, Oregon, USA)
and incubated in the same solution containing a mouse
anti-cytochrome c monoclonal IgG2a antibody (1 : 500; clone
37BA11; catalog number MSA07; MitoSciences) and a mouse
anti-complex V𝛼 (ATP synthase subunit alpha) monoclonal
IgG2b antibody (1 : 500; clone 15H4C4; Cat. number MSA07;
MitoSciences) for 2 days at 4∘C. After washes as above, the
brains were incubated in the same solution containing a goat
anti-mouse IgG2a antibody conjugated to fluorescein isothio-
cyanate (FITC) (1 : 500; Cat. number MSA07; MitoSciences)
and a goat anti-mouse IgG2b antibody conjugated to Texas
Red (1 : 500; Cat. number MSA07; MitoSciences) overnight
at 4∘C. Then, the brains were rinsed in PBS containing
0.1% Tween 20, mounted on Superfrost Plus glass slides
(Fisher Scientific, MA, USA) and coverslipped using Prolong
(Invitrogen) as an antifade reagent.
The specificity of the anti-cytochrome c antibody was
tested by Western blot using larval sea lamprey total protein
from combined spinal cord and brain samples homogenates
(𝑛 = 2). For extract preparation, the sample was lysed
in TNN buffer (50mM Tris, 150mM NaCl, and 0.5 NP-
40) with protease inhibitor cocktail (Sigma). The protein
concentration was measured by the Bradford assay: 30mg
lysate was loaded per well for SDS-PAGE and proteins
were transferred onto PVDF or nitrocellulose membranes.
Western analysis was conducted by incubation with the anti-
cytochrome c antibody (1 : 1000) overnight at 4∘C, followed by
incubation with HRP-tagged secondary anti-mouse antibody
(1 : 5000; 1 h at room temperature; Americana Qualex, San
Clemente, CA, USA). Proteins were visualized using ECL
(GE Health Sciences, Piscataway, NJ, USA). The antibody
recognized a single band of about 13 kDa (Figure 5(d)),
which corresponds to the molecular size of cytochrome
c of mammalian species. Colocalization of cytochrome c
and complex V𝛼 immunoreactivities in neurons of normal
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animals (see Results) further confirmed the specificity of both
antibodies and the validity of the monoclonal anti-complex
V𝛼 antibody as a mitochondrial marker. As a control for
secondary antibodies, the incubation with primary antibod-
ies was omitted. No immunoreactivity was observed in these
experiments.
2.6. Taxol (Placlitaxel) Treatment. Immediately after the
complete SC transection, a small piece of Gelfoam soaked
with 10 𝜇L of either 1mM Taxol (Molecular Probes, Eugene,
OR, USA) in ethanol (𝑛 = 7) or 10 𝜇L of ethanol alone
(𝑛 = 5) was placed on the top of the SC at the site of injury.
Animals recovered for 1 or 2 weeks and their brains/spinal
cords were processed for detection of activated caspase-8 as
above. Control animals that did not receive Taxol treatment
were always processed in parallel with experimental animals
treated with Taxol.
2.7. Imaging and Preparation of Figures. Photomicrographs
were taken using a Nikon Eclipse 80i microscope equipped
with a CoolSNAP ES (Roper Scientific, USA) camera or
with a spectral confocal microscope (model TCS-SP2; Leica,
Wetzlar, Germany). Images were always taken under the
same microscope conditions for control or treated animals.
Quantification of mean fluorescent intensity of each identi-
fiable neuron was done using the histogram function of the
Fiji software. For the preparation of figures, brightness and
contrast were minimally adjusted using Adobe Photoshop
CC software and lettering was added.
2.8. Statistical Analyses. Statistical analysis was carried out
using Prism 6 (GraphPad software, La Jolla, CA). Data
were presented as mean ± SEM. Normality of the data was
determined by the D’Agostino-Pearson normality test. The
correlation (Pearson test) between fluorescence intensity of
the FLICA labeling (present results) and the regenerative
ability of the descending neurons [23] was analyzed. Differ-
ences in fluorescence intensity between control and Taxol
treated animalswere analyzed bymeans of a two-tailed paired
Student’s 𝑡-test.
3. Results
3.1. Levels of Activated Caspases 2 Weeks after a Complete SC
Transection Correlate Significantly with the Long-Term Regen-
erative Ability of Identifiable Neurons. In previous studies
[23, 38], some reticulospinal neurons of the sea lamprey were
identified as “bad regenerators” (M1, M2, M3, I1, I2, Mth, B1,
B2, B3, and B4) because their axons had a low probability of
regenerating after axotomy due to a complete SC transection.
In later studies, almost the same cells were identified as “poor
survivor” neurons because they have a high likelihood of
degenerating and dying after axotomy (the M1, M2, M3, I1,
I2, Mth, B1, B3, and B4 neurons) [28].
Also, previous studies revealed that bad regenerator/poor
survivor neurons show high levels of activated caspases in the
first 2 weeks following a complete SC transection as revealed
by FLICA labeling [30–32] and that intense FLICA labeling
and TUNEL staining are observed in bad regenerators several
weeks after a complete SC transection [32]. However, these
studies never established a statistical correlation between the
intensity of FLICA labeling in the first 2 weeks after the injury
and the long-term regenerative ability of the individually
identifiable neurons. Here, we used a poly-caspase FLICA
reagent (FAM-VAD-FMK) to detect all activated caspases
2 weeks following a complete SC transection (Figures 1(a)
and 1(b)) and correlated the levels of activated caspases in
identifiable neurons with their known regenerative ability (%
of times inwhich a specific neuron regenerates its axon across
the lesion site; based on the results of [23]). This revealed a
significant correlation (𝑝 = 0.0044; Pearson test) between
the level of activated caspases (fluorescence intensity) and
the known regenerative ability of the identifiable neurons
(Figure 1(c)).
3.2. Long-Term Detection of Specific Activated Caspases in
Bad Regenerators. In previous studies, we reported intense
FLICA labeling 2 weeks after lesion in bad regenerators using
the FLICA reagent specific for the detection of activated
caspase-8 (FAM-LETD-FMK) [30]. Here, we extended our
analyses and observed that at, one month posttransection,
FAM-LETD-FMK labeling is still observed in “poor survivor”
SC projecting neurons of the brainstem (M1, M2, M3, I1, I2,
Mth, B1, B3, and B4; Figure 2).
Incubation of the brains with the FLICA reagent FAM-
DEVD-FMK revealed the presence of activated caspase-3
or caspase-7 in identified SC projecting brainstem neurons
at 10 weeks posttransection (Figure 3), but not in neurons
of untransected control animals (Figure 3(a)). Little or no
labeling was observed 6 weeks posttransection (not shown).
Intense FAM-DEVD-FMK labeling was observed in the cell
bodies of identified spinal-projecting neurons known to be
“poor survivors” (the M1, M2, M3, I1, I2, Mth, B1, B3,
and B4 neurons). Interestingly, the morphology of these
neurons differed from that of the same neurons in control
animals. The neurons seemed to have suffered atrophy and
had fewer dendrites than normal neurons (Figure 3(b)–3(d)).
The delay between the detection of activated caspase-8 and
the detection of activated caspase-3/caspase-7 may account
for the slow process of cell death observed in these neurons
after axotomy [28].
3.3. Staining with Fluoro-Jade C Is Consistent with Protracted
Degeneration of Axotomized Spinal-Projecting Neurons. FJC
staining (Figure 4) was not observed in identifiable spinal-
projecting neurons of control unlesioned animals (Fig-
ure 4(b)). Four months after the SC transection, intense FJC
labeling was observed in swollen identifiable reticulospinal
neurons previously identified as “bad regenerators” (M1, M2,
M3, I1, I2, Mth, B1, B3, and B4) (Figure 4(a)). This was
consistent with the results of Busch and Morgan [29] and
extended the period in which FJC staining was detected
to 4 months, confirming that spinal-projecting neurons of
lampreys degenerate very slowly after SCI.
3.4. Cytochrome c Is Not Released fromMitochondria of Spinal-
Projecting Neurons after the Complete SC Transection. The
presence of activated caspase-8 in descending neurons 2 [30]
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Figure 1: Confocal photomicrographs of dorsal views of whole-mounted brains of larval sea lampreys showing FAM-VAD-FMK labeling in
axotomized identified spinal-projecting neurons 2weeks after SCI. (a) I1, I3, and I4 neurons. (b)Mth andMth󸀠 neurons.Note that fluorescence
intensity in I1 andMth neurons is higher than I3, I4, andMth󸀠 neurons. Rostral is to the top and the ventricle is to right in all figures. (c) Linear
regression analysis shows the inverse correlation between the regenerative ability of identified SC projecting neurons and their fluorescence
intensity reflecting caspase activation (95% confidence intervals for slope−1.168 to−0,2588; Sy.x = 20.50;𝑝 = 0.0044).The dotted lines indicate
the 95% confidence interval. Identity of RS neurons is shown adjacent to their corresponding data points. I1, I3, and I4: Müller cells of the
isthmic region; Mth: Mauthner cell; Mth󸀠: auxiliary Mauthner cell. Scale bars: 50𝜇m.
and 4 (see above) weeks after a complete SC transection
suggests that the extrinsic apoptotic pathway is activated in
descending neurons after axotomy. To determine whether
the intrinsic pathway is also involved in the death of these
neurons after axotomy, we performed double immunofluo-
rescence experiments in whole-mounted brain preparations,
using anti-cytochrome c and anti-complex V𝛼 antibodies.
Cytochrome c release from mitochondria is a key step in
the development of the intrinsic apoptotic pathway because
it allows the formation of the apoptosome complex and
subsequent activation of caspase-9 (see above).
In immunofluorescence experiments, colocalization of
cytochrome c and complex V𝛼 immunoreactivities was
observed as a cluster of punctuate staining in the cell
bodies of all identifiable spinal-projecting neurons in control
unlesioned animals (Figure 5(a)) and in animals 2 and 4
weeks posttransection (Figures 5(b) and 5(c)). This shows
that at time points after SCI in which activated caspase-8 is
already detected in the cell bodies of “poor survivor” neurons
([30]; present results), cytochrome c has not been released
from the mitochondria.
3.5. Taxol Treatment Prevents Caspase-8 Retrograde Acti-
vation in Spinal-Projecting Neurons after SCI. The initial
activation of caspase-8 at the site of injury, followed by its
progressively proximal appearance toward the cell bodies of
“poor survivor” SC projecting neurons suggests that either
the signal/s that activate caspase-8 and/or activated caspase-
8 itself is retrogradely transported from the site of axotomy
to the cell bodies [31]. To determine whether the centripetal
movement of caspase-8 activation depends on microtubule-
based retrograde transport from the site of axotomy, we
applied themicrotubule stabilizer Taxol (placlitaxel) to the SC
at the site of a complete transection. Pieces of Gelfoam soaked
either with ethanol (control) or with a solution of 1mMTaxol
in ethanol were inserted into the lesion site. Brains from









Figure 2: Photomicrographs of dorsal views of whole-mounted brains of larval sea lampreys showing FAM-LETD-FMK labeling in
axotomized descending neurons 4 weeks after SCI ((a) and (b)). Rostral is to the top and the ventricle is to left in all figures. I1: Müller


















Figure 3: Photomicrographs of dorsal views of the whole-mounted brain of larval sea lampreys showing the presence of intense FAM-DEVD-
FMK labeling in “poor survivor” spinal-projecting neurons 10weeks after a complete spinal cord transection ((b)–(d)) as compared to controls
without injury (a). Note the absence of labeling in an I5 cell in (c). Rostral is to the top and the ventricle to the left in all figures. B1, B3, and
B4: Müller cells of the bulbar region; I1 and I5: Müller cells of the isthmic region; M3: Müller cell 3; Mth: Mauthner cell. Scale bars: 50 𝜇m in
(a)–(c) and 15 𝜇m in (d).













Figure 4: Photomicrographs of dorsal views of whole-mounted brains of larval sea lampreys showing Fluoro-Jade C staining in swollen
reticulospinal neurons 4 months after a complete SC transection (a). Note the absence of labeling in control animals without SC transection
(b). The star indicates the location of the ventricle. Rostral is to the top in the figures. B1, B3, and B4: Müller cells of the bulbar region; Mth:

























Figure 5: Photomicrographs of dorsal views of whole-mounted brains of larval sea lampreys showing colocalization of cytochrome c and
complex V𝛼 immunoreactivities (arrows) in identifiable reticulospinal neurons of control animals (a) and animals 2 (b) and 4 (c) weeks after
a complete SCI. Rostral is to the top and the ventricle to the left in all figures. (d) Western blot showing that the anti-cytochrome c antibody
recognizes a single band of the expected molecular weight for cytochrome c (about 13 kDa). B3 and B4: Müller cells of the bulbar region; Cc:
cytochrome c; Mth: Mauthner cell. Scale bars: 20𝜇m in (a) and (b) and 15 𝜇m in (c).
these animals were analyzed 2 weeks later for the presence
of activated caspase-8 as above (Figure 6). Intense FAM-
LETD-FMK labeling was observed in “poor survivor” spinal-
projecting neurons of control animals (Figures 6(b) and
6(d)), but, in animals treated with Taxol, these neurons were
either unlabeled or exhibited only veryweak labeling (Figures
6(a) and 6(b)). Statistical analyses revealed a significant
difference in caspase-8 activation (fluorescence intensity)
between control and Taxol treated animals (𝑝 < 0.0001; two-
tailed paired Student’s 𝑡-test; Figure 6(e)).
To determine whether the Taxol treatment caused inhibi-
tion of caspase-8 activation itself or inhibited microtubule-
based retrograde transport of caspase-8 activity from the
site of axotomy, some animals were studied 1 week post-
transection (Figure 7). As in the animals studied 2 weeks
after injury, no labeling was observed in spinal-projecting
neurons (Figure 7(b)). However, labeling was observed in the
descending axons close to the site of injury (Figure 7(a)).
This indicates that the Taxol treatment inhibited the transport
of the signal/s that activate caspase-8 or the transport of






































Figure 6: Photomicrographs of dorsal views of whole-mounted brains of larval sea lampreys showing reduced FAM-LETD-FMK labeling in
identifiable “poor survivor” SC projecting neurons after Taxol ((a) and (c)) treatment as compared with control animals treated with ethanol
alone ((b) and (d)). (e) Graph revealing a significant difference (𝑝 < 0.0001; two-tailed paired Student’s 𝑡-test) in fluorescence intensity of the
FAM-LETD-FMK labeling in identifiable neurons of control and Taxol treated animals. Rostral is to the top in all figures. The ventricle is to
the right in all figures. B1 and B3–B5: Müller cells of the bulbar region; I1 and I2: Müller cells of the isthmic region; Mth: Mauthner cell. Scale
bars: 50 𝜇m in (a), (c), and (d) and 25 𝜇m in (b).
activated caspase-8 itself but did not prevent the initial
process of caspase-8 activation.
4. Discussion
Present findings, together with previous results [28–32], show
that, in lampreys, axotomy due to SCI consistently causes
retrograde degeneration and apoptotic death in individually
identified spinal cord-projecting neuron; that is, they are
“poor survivors,” and that these are the same cells that are
“bad regenerators” [23]. The persistence of FJC staining 4
months after the injury, together with the late detection of
activated caspase-3/caspase-7 (present results) and TUNEL
staining [28] in these neurons prior to their disappearance,
indicates that axotomy in the SC causes the activation of a
very slow process of cell death in SC projecting neurons. The
presence of activated caspase-8 and the lack of cytochrome
c release indicate that the extrinsic apoptotic pathway is the
main mediator of this cell death process after axotomy. Our
results also suggest that the centripetal activation of caspases
depends on microtubule-based retrograde transport of stress
signals.
Studies in mammals have shown that a proportion of
SC projecting neurons die or undergo atrophy after damage
to their axon at the spinal level and that this may depend
on activation of an apoptotic process (see Introduction).
Clearly, prevention of this process would be a prerequisite for
designing therapies to promote regeneration of descending









Figure 7: Photomicrographs of dorsal views of the whole-mounted spinal cord (a) and brain (b) of a larval sea lamprey treated with Taxol
showing the presence of FAM-LETD-FMK labeling in the tip of descending axons 1 week after treatment (arrows in (a)) and the absence of
labeling in identifiable descending neurons of the brain (b). Rostral is to the right in (a) and to the top in (b).The ventricle is to the left in (b).
B1, B3, and B4: Müller cells of the bulbar region; Mth: Mauthner cell. Scale bars: 40𝜇m in (a) and 50𝜇m in (b).
pathways after SCI [39]. Therefore, it is of great importance
to understand the molecular processes that lead to the
retrograde degeneration of injured descending pathways after
SCI. This could also inform research in other types of CNS
injuries like optic nerve injuries or stroke, where apoptotic
processes are also activated [40–45]. Previous results in
lampreys showed that axotomy at the spinal level initially
leads to activation of caspase-8 in the injured axon at the site
of injury and subsequently in the cell body of descending
neurons [30]. This is in agreement with reports showing
that axotomy induces caspase-8 activation in retinal ganglion
[44, 45] and olfactory receptor [46] neurons. Other studies
have also revealed the importance of caspase-2 and caspase-
6 in causing the death of retinal ganglion cells following
optic nerve transections [41–43]. Experiments using the
microtubule stabilizer Taxol show that, both in SC projecting
neurons (present results) and in olfactory neurons [46], the
retrograde activation of caspase-8 in the perikaryon after
axotomydepends onmicrotubule-based retrograde transport
from the injured axon. In olfactory neurons, the appearance
of activated caspase-8 in the cell body depended on the
microtubule-based retrograde transport of activated caspase-
8, probably by its association with dynactin p150Glued [46].
We cannot rule out the possibility that other retrograde
signals may promote activation of local procaspase-8 in the
cell body and along the axon of SC projecting neurons. As
in olfactory neurons [46], axotomy of SC projecting neurons
in lampreys caused sequential activation of caspase-8 and
caspase-3 or caspase-7 (present results). Our results indicate
that Taxol, or other microtubule stabilizers like epothilone
B, may be a beneficial therapeutic option after SCI not only
to promote axonal regeneration, as previously reported for
axons in the mammalian SC [47, 48] and optic nerve [49],
but also to avoid the retrograde degeneration of SC projecting
neurons by preventing the retrograde transport of caspase-
8 or other stress signals. Of note, the retrograde activation
of neuronal degeneration might be slow in lampreys due to
slower microtubule dynamics that occur in cold-living fishes
[50, 51].
Studies in mammals also reported increased levels of
activated caspase-8 in the SC after injury [52–55]. Because
these analyses used immunoblots of SC homogenates [52–
55], it is not known if the activation of caspase-8 occurred
in intraspinal cells, in descending axons or in both. Neutral-
ization of the proapoptotic cytokines tumor necrosis factor-
related apoptosis-inducing ligand [55] or tumor necrosis
factor-alpha [55] promoted a decrease in caspase-8 activation
after SCI. Dependence receptors could also be important
players in the initiation of apoptotic processes after CNS
damage. Dependence receptors, like Neogenin or UNC5
receptors, trigger extrinsic apoptotic processes in the absence
of their ligands [56, 57]. Recent work has shown that an inhi-
bition of Neogenin localization in lipid rafts promotes sur-
vival and axonal growth after SC or optic nerve injuries [58].
Interestingly, recent work in lampreys has also shown that
knock down of Neogenin in descending neurons of lampreys
promotes axonal regeneration [22]. Another study in lam-
preys has also shown that knockdown of the small GTPase
RhoA enhances axon regeneration and inhibits retrograde
apoptosis following SCI [59]. The results of our experiments
in lampreys could also be translated to mammalian injured
descending axons because mechanisms of caspase-activated
apoptosis are evolutionary conserved [60, 61]. The sea lam-
prey could be an interesting in vivo animal model to study
the role of proapoptotic cytokines, dependence receptors, or
other molecules like RhoA in the intra-axonal activation of
caspase-8 after SCI.
Abbreviations Used in the Figures




I1–I6: Müller cells of the isthmic region
M1–M4: Müller cells 1 to 4
Mth: Mauthner cell
Mth󸀠: Auxiliary Mauthner cell
SCI: Spinal cord injury.
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and M. Bähr, “Activation of caspase-3 in axotomized rat retinal
ganglion cells in vivo,” FEBS Letters, vol. 453, no. 3, pp. 361–364,
1999.
[5] J. L. Vanderluit, L. T.McPhail, K. J. L. Fernandes et al., “Caspase-
3 is activated following axotomy of neonatal facial motoneurons
and caspase-3 gene deletion delays axotomy-induced cell death
in rodents,” European Journal of Neuroscience, vol. 12, no. 10, pp.
3469–3480, 2000.
[6] Y.-M. Chan, L.-W. Yick, H. K. Yip, K.-F. So, R. W. Oppenheim,
andW.Wu, “Inhibition of caspases promotes long-term survival
and reinnervation by axotomized spinal motoneurons of dener-
vatedmuscle in newborn rats,” Experimental Neurology, vol. 181,
no. 2, pp. 190–203, 2003.
[7] E. J. Fry, H. B. Stolp, M. A. Lane, K. M. Dziegielewska, and N. R.
Saunders, “Regeneration of Supraspinal Axons after Complete
Transection of theThoracic Spinal Cord in Neonatal Opossums
(Monodelphis domestica),” Journal of Comparative Neurology,
vol. 466, no. 3, pp. 422–444, 2003.
[8] E. R. Feringa and H. L. Vahlsing, “Labeled corticospinal
neurons one year after spinal cord transection,” Neuroscience
Letters, vol. 58, no. 3, pp. 283–286, 1985.
[9] B. C. Hains, J. A. Black, and S. G. Waxman, “Primary cortical
motor neurons undergo apoptosis after axotomizing spinal cord
injury,” Journal of Comparative Neurology, vol. 462, no. 3, pp.
328–341, 2003.
[10] K. L. H. Wu, S. H. H. Chan, Y.-M. Chao, and J. Y. H. Chan,
“Expression of pro-inflammatory cytokine and caspase genes
promotes neuronal apoptosis in pontine reticular formation
after spinal cord transection,” Neurobiology of Disease, vol. 14,
no. 1, pp. 19–31, 2003.
[11] B. H. Lee, K. H. Lee, U. J. Kim et al., “Injury in the spinal cord
may produce cell death in the brain,” Brain Research, vol. 1020,
no. 1-2, pp. 37–44, 2004.
[12] N. Klapka, S. Hermanns, G. Straten et al., “Suppression of
fibrous scarring in spinal cord injury of rat promotes long-
distance regeneration of corticospinal tract axons, rescue of
primary motoneurons in somatosensory cortex and significant
functional recovery,” European Journal of Neuroscience, vol. 22,
no. 12, pp. 3047–3058, 2005.
[13] G. Holmes and W. P. May, “On the Exact Origin of the
Pyramidal Tracts in Man and other Mammals,” Journal of the
Royal Society of Medicine, vol. 2, pp. 92–100, 1909.
[14] J. L. Nielson, I. Sears-Kraxberger, M. K. Strong, J. K. Wong, R.
Willenberg, andO. Steward, “Unexpected survival of neurons of
origin of the pyramidal tract after spinal cord injury,”The Jour-
nal of Neuroscience, vol. 30, no. 34, pp. 11516–11528, 2010.
[15] J. L. Nielson, M. K. Strong, and O. Steward, “A reassessment
of whether cortical motor neurons die following spinal cord
injury,” Journal of Comparative Neurology, vol. 519, no. 14, pp.
2852–2869, 2011.
[16] M. C. Rodicio and A. Barreiro-Iglesias, “Lampreys as an animal
model in regeneration studies after spinal cord injury,” Revista
de Neurologı́a, vol. 55, no. 3, pp. 157–166, 2012.
[17] M. I. Becker and D. Parker, “Changes in functional properties
and 5-HT modulation above and below a spinal transection in
lamprey,” Frontiers in Neural Circuits, vol. 8, pp. 1–18, 2015.
[18] M. E. Cornide-Petronio, B. Fernández-López, A. Barreiro-
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